Institution/investigator-initiated clinical trials in Canada

Area of Science:

• Clinical Research
• Regulatory Affairs
• Canadian Healthcare System

Background:

• Institution/investigator-initiated clinical trials in Canada face stringent regulatory requirements.
• These regulations often mirror those applied to large pharmaceutical manufacturers.
• Compliance is crucial for the ethical and legal conduct of trials.

Purpose of the Study:

• To outline the regulatory responsibilities for investigator-initiated clinical trials in Canada.
• To provide a comprehensive guide on actions required before, during, and after trial conduct.
• To ensure investigators understand and adhere to Canadian clinical trial regulations.

Main Methods:

• Review of Canadian regulatory guidelines and requirements for clinical trials.
• Identification of key procedural steps for investigators.
• Documentation of responsibilities throughout the trial lifecycle.

Main Results:

• Investigators must file a Clinical Trial Application.
• Specific responsibilities exist pre-trial, during the trial, and post-trial.
• Adherence to Good Clinical Practice (GCP) principles is implied.

Conclusions:

• Successful conduct of investigator-initiated trials necessitates thorough understanding and implementation of regulatory processes.
• Proactive engagement with regulatory requirements minimizes risks and ensures trial integrity.
• This guidance serves as a critical resource for Canadian investigators.